Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl E Anderson

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Clinical Chemistry|May 30, 2019
CommentaryKarl E Anderson
Clinical and Translational Science|April 19, 2011
A career in patient-oriented research on human leukemia: The 2010 E. H. Ahrens, Jr. Award to Emil J Freireich, M.DKarl E Anderson
Clinical and Translational Science|May 7, 2010
What can be done to protect the translational investigator? : The environment for investigator-initiated clinical research is changingKarl E Anderson
Molecular Genetics and Metabolism|July 18, 2019
Acute hepatic porphyrias: Current diagnosis & managementKarl E Anderson
Hepatology (Baltimore, Md.)|December 26, 2006
Porphyria cutanea tarda: a possible role for ascorbic acidKarl E Anderson
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 28, 2020
Expanding Experience With Liver Transplantation in Acute Intermittent PorphyriaAkshata Moghe, Karl E Anderson
The American Journal of Medicine|September 2, 2006
Open-label study of hemin for acute porphyria: clinical practice implicationsKarl E Anderson, Stephen Collins
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|September 26, 2002
Assessing and managing drug-nutrient interactionsKarl E Anderson, David J Greenblatt
The Journal of Pharmacology and Experimental Therapeutics|November 22, 2015
Protoporphyrin IX: the Good, the Bad, and the UglyMadhav Sachar, Karl E Anderson, Xiaochao Ma
Frontiers in Genetics|August 22, 2022
Case Report: Lack of Response to Givosiran in a Case of ALAD PorphyriaErica Graff, Karl E Anderson, Cynthia Levy
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Clinical Chemistry|May 30, 2019
CommentaryKarl E Anderson
Clinical and Translational Science|April 19, 2011
A career in patient-oriented research on human leukemia: The 2010 E. H. Ahrens, Jr. Award to Emil J Freireich, M.DKarl E Anderson
Clinical and Translational Science|May 7, 2010
What can be done to protect the translational investigator? : The environment for investigator-initiated clinical research is changingKarl E Anderson
Molecular Genetics and Metabolism|July 18, 2019
Acute hepatic porphyrias: Current diagnosis & managementKarl E Anderson
Hepatology (Baltimore, Md.)|December 26, 2006
Porphyria cutanea tarda: a possible role for ascorbic acidKarl E Anderson
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 28, 2020
Expanding Experience With Liver Transplantation in Acute Intermittent PorphyriaAkshata Moghe, Karl E Anderson
The American Journal of Medicine|September 2, 2006
Open-label study of hemin for acute porphyria: clinical practice implicationsKarl E Anderson, Stephen Collins
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|September 26, 2002
Assessing and managing drug-nutrient interactionsKarl E Anderson, David J Greenblatt
The Journal of Pharmacology and Experimental Therapeutics|November 22, 2015
Protoporphyrin IX: the Good, the Bad, and the UglyMadhav Sachar, Karl E Anderson, Xiaochao Ma
Frontiers in Genetics|August 22, 2022
Case Report: Lack of Response to Givosiran in a Case of ALAD PorphyriaErica Graff, Karl E Anderson, Cynthia Levy
Pageof 11